These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 34850240)
1. Checkpoint Inhibition Reduces the Threshold for Drug-Specific T-Cell Priming and Increases the Incidence of Sulfasalazine Hypersensitivity. Hammond S; Olsson-Brown A; Grice S; Gibson A; Gardner J; Castrejón-Flores JL; Jolly C; Fisher BA; Steven N; Betts C; Pirmohamed M; Meng X; Naisbitt DJ Toxicol Sci; 2022 Feb; 186(1):58-69. PubMed ID: 34850240 [TBL] [Abstract][Full Text] [Related]
2. Stimulation of human T cells with sulfonamides and sulfonamide metabolites. Castrejon JL; Berry N; El-Ghaiesh S; Gerber B; Pichler WJ; Park BK; Naisbitt DJ J Allergy Clin Immunol; 2010 Feb; 125(2):411-418.e4. PubMed ID: 20159253 [TBL] [Abstract][Full Text] [Related]
3. Cross-reactivity in drug hypersensitivity reactions to sulfasalazine and sulfamethoxazole. Zawodniak A; Lochmatter P; Beeler A; Pichler WJ Int Arch Allergy Immunol; 2010; 153(2):152-6. PubMed ID: 20413982 [TBL] [Abstract][Full Text] [Related]
4. Metabolic and chemical origins of cross-reactive immunological reactions to arylamine benzenesulfonamides: T-cell responses to hydroxylamine and nitroso derivatives. Castrejon JL; Lavergne SN; El-Sheikh A; Farrell J; Maggs JL; Sabbani S; O'Neill PM; Park BK; Naisbitt DJ Chem Res Toxicol; 2010 Jan; 23(1):184-92. PubMed ID: 19954178 [TBL] [Abstract][Full Text] [Related]
5. Detection of Hepatic Drug Metabolite-Specific T-Cell Responses Using a Human Hepatocyte, Immune Cell Coculture System. Ali SE; Meng X; Kafu L; Hammond S; Zhao Q; Ogese M; Sison-Young R; Jones R; Chan B; Livoti L; Sun Y; Sun L; Liu H; Topping A; Goldring C; Zhang F; Naisbitt DJ Chem Res Toxicol; 2023 Mar; 36(3):390-401. PubMed ID: 36812109 [TBL] [Abstract][Full Text] [Related]
6. Development of an Improved T-cell Assay to Assess the Intrinsic Immunogenicity of Haptenic Compounds. Ogese MO; Watkinson J; Lister A; Faulkner L; Gibson A; Hillegas A; Sakatis MZ; Park BK; Naisbitt DJ Toxicol Sci; 2020 Jun; 175(2):266-278. PubMed ID: 32159798 [TBL] [Abstract][Full Text] [Related]
7. The Effect of Inhibitory Signals on the Priming of Drug Hapten-Specific T Cells That Express Distinct Vβ Receptors. Gibson A; Faulkner L; Lichtenfels M; Ogese M; Al-Attar Z; Alfirevic A; Esser PR; Martin SF; Pirmohamed M; Park BK; Naisbitt DJ J Immunol; 2017 Aug; 199(4):1223-1237. PubMed ID: 28687658 [TBL] [Abstract][Full Text] [Related]
8. Diagnosis of sulfonamide hypersensitivity reactions by in-vitro "rechallenge" with hydroxylamine metabolites. Rieder MJ; Uetrecht J; Shear NH; Cannon M; Miller M; Spielberg SP Ann Intern Med; 1989 Feb; 110(4):286-9. PubMed ID: 2913915 [TBL] [Abstract][Full Text] [Related]
9. Negative regulation by PD-L1 during drug-specific priming of IL-22-secreting T cells and the influence of PD-1 on effector T cell function. Gibson A; Ogese M; Sullivan A; Wang E; Saide K; Whitaker P; Peckham D; Faulkner L; Park BK; Naisbitt DJ J Immunol; 2014 Mar; 192(6):2611-2621. PubMed ID: 24510967 [TBL] [Abstract][Full Text] [Related]
10. Detection of Primary T Cell Responses to Drugs and Chemicals in HLA-Typed Volunteers: Implications for the Prediction of Drug Immunogenicity. Faulkner L; Gibson A; Sullivan A; Tailor A; Usui T; Alfirevic A; Pirmohamed M; Naisbitt DJ; Kevin Park B Toxicol Sci; 2016 Dec; 154(2):416-429. PubMed ID: 27637899 [TBL] [Abstract][Full Text] [Related]
11. The Use of Immune Checkpoint Inhibitors in Oncology and the Occurrence of AKI: Where Do We Stand? Franzin R; Netti GS; Spadaccino F; Porta C; Gesualdo L; Stallone G; Castellano G; Ranieri E Front Immunol; 2020; 11():574271. PubMed ID: 33162990 [TBL] [Abstract][Full Text] [Related]
12. Interaction of sulfonamide derivatives with the TCR of sulfamethoxazole-specific human alpha beta+ T cell clones. von Greyerz S; Zanni MP; Frutig K; Schnyder B; Burkhart C; Pichler WJ J Immunol; 1999 Jan; 162(1):595-602. PubMed ID: 9886437 [TBL] [Abstract][Full Text] [Related]
13. Deciphering Adverse Drug Reactions: In Vitro Priming and Characterization of Vancomycin-Specific T Cells From Healthy Donors Expressing HLA-A*32:01. Ogese MO; Lister A; Gardner J; Meng X; Alfirevic A; Pirmohamed M; Park BK; Naisbitt DJ Toxicol Sci; 2021 Aug; 183(1):139-153. PubMed ID: 34175955 [TBL] [Abstract][Full Text] [Related]
14. Dapsone and Nitroso Dapsone Activation of Naı̈ve T-Cells from Healthy Donors. Alzahrani A; Ogese M; Meng X; Waddington JC; Tailor A; Farrell J; Maggs JL; Betts C; Park BK; Naisbitt D Chem Res Toxicol; 2017 Dec; 30(12):2174-2186. PubMed ID: 29045131 [TBL] [Abstract][Full Text] [Related]